The role of SHIP in cytokine-induced signaling (original) (raw)
References
Aman MJ, Walk SF, March ME, Su HP, Carver DJ, Ravichandran KS (2000) Essential role for the C-terminal noncatalytic region of SHIP in FcγRIIB1-mediated inhibitory signaling. Mol Cell Biol 20:3576–3589 PubMedCAS Google Scholar
Birle D, Bottini N, Williams S, Huynh H, deBelle I, Adamson E, Mustelin T (2002) Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. J Immunol 169:286–291 PubMedCAS Google Scholar
Boer AK, Drayer AL, Vellenga E (2001) Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells. Leukemia 15:1750–7175 PubMedCAS Google Scholar
Bolland S, Pearse RN, Kurosaki T, Ravetch JV (1998) SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509–516 PubMedCAS Google Scholar
Bone H, Welham MJ (2000) Shc associates with the IL-3 receptor β subunit, SHIP and Gab2 following IL-3 stimulation. Contribution of Shc PTB and SH2 domains. Cell Signal 12:183–194 PubMedCAS Google Scholar
Brauweiler AM, Tamir I, Cambier JC (2000) Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP. Immunol Rev 176:69–74 PubMedCAS Google Scholar
Brauweiler A, Tamir I, Marschner S, Helgason CD, Cambier JC (2001) Partially distinct molecular mechanisms mediate inhibitory FcγRIIB signaling in resting and activated B cells. J Immunol 167:204–211 PubMedCAS Google Scholar
Bruyns C, Pesesse X, Moreau C, Blero D, Erneux C (1999) The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes. Biol Chem 380:969–974 PubMedCAS Google Scholar
Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240–4245 PubMedCAS Google Scholar
Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A (1998) Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Curr Biol 8:1069–1077 PubMedCAS Google Scholar
Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, et al. (2001) The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409:92–97 PubMedCAS Google Scholar
Coggeshall KM (1998) Inhibitory signaling by B cell Fcγ RIIb. Curr Opin Immunol 10:306–312 PubMedCAS Google Scholar
Daigle I, Yousefi S, Colonna M, Green DR, Simon HU (2002) Death receptors bind SHP-1 and block cytokine-induced antiapoptotic signaling in neutrophils. Nat Med 8:61–67 PubMedCAS Google Scholar
Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G (1996) The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Proc Natl Acad Sci USA 93:1689–1693 PubMedCAS Google Scholar
Damen JE, Liu L, Ware MD, Ermolaeva M, Majerus PW, Krystal G (1998) Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation. Blood 92:1199–1205 PubMedCAS Google Scholar
Damen JE, Ware MD, Kalesnikoff J, Hughes MR, Krystal G (2001) SHIP’s C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation. Blood 97:1343–1351 PubMedCAS Google Scholar
de Koning JP, Schelen AM, Dong F, van Buitenen C, Burgering BM, Bos JL, Lowenberg B, Touw IP (1996) Specific involvement of tyrosine 764 of human granulocyte colony-stimulating factor receptor in signal transduction mediated by p145/Shc/GRB2 or p90/GRB2 complexes. Blood 87:132–140 PubMed Google Scholar
Drachman JG, Kaushansky K (1997) Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci USA 94:2350–2355 PubMedCAS Google Scholar
Dunant NM, Wisniewski D, Strife A, Clarkson B, Resh MD (2000) The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells. Cell Signal 12:317–326 PubMedCAS Google Scholar
Dyson JM, O’Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA (2001) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155:1065–1079 PubMedCAS Google Scholar
Feng Y, Wente SR, Majerus PW (2001) Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export. Proc Natl Acad Sci USA 98:875–879 PubMedCAS Google Scholar
Fox JA, Ung K, Tanlimco SG, Jirik FR (2002) Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol 169:49–54 PubMedCAS Google Scholar
Galandrini R, Tassi I, Morrone S, Lanfrancone L, Pelicci P, Piccoli M, Frati L, Santoni A (2001) The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity. Eur J Immunol 31: 2016–2025 PubMedCAS Google Scholar
Geier SJ, Algate PA, Carlberg K, Flowers D, Friedman C, Trask B, Rohrschneider LR (1997) The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89:1876–1885 PubMedCAS Google Scholar
Giallourakis C, Kashiwada M, Pan PY, Danial N, Jiang H, Cambier J, Coggeshall KM, Rothman P (2000) Positive regulation of interleukin-4-mediated proliferation by the SH2-containing inositol-50-phosphatase. J Biol Chem 275: 29275–29282 PubMedCAS Google Scholar
Giuriato S, Payrastre B, Drayer AL, Plantavid M, Woscholski R, Parker P, Erneux C, Chap H (1997) Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem 272:26857–26863 PubMedCAS Google Scholar
Harmer SL, DeFranco AL (1999) The src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes. J Biol Chem 274:12183–12191 PubMedCAS Google Scholar
Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12:1610–1620 PubMedCAS Google Scholar
Hocking LJ, Herbert CA, Nicholls RK, Williams F, Bennett ST, Cundy T, Nicholson GC, Wuyts W, Van Hul W, Ralston SH (2001) Genome-wide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet 69:1055–1061 PubMedCAS Google Scholar
Hori H, Sasaoka T, Ishihara H, Wada T, Murakami S, Ishiki M, Kobayashi M (2002) Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51:2387–2394 PubMedCAS Google Scholar
Horn S, Meyer J, Heukeshoven J, Fehse B, Schulze C, Li S, Frey J, Poll S, Stocking C, Jucker M (2001) The inositol 5-phosphatase SHIP is expressed as 145-and 135-kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro. Leukemia 15:112–120 PubMedCAS Google Scholar
Huber M, Helgason CD, Scheid MP, Duronio V, Humphries RK, Krystal G (1998) Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J 17:7311–7319 PubMedCAS Google Scholar
Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G (1998a) The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 95:11330–11335 PubMedCAS Google Scholar
Huber M, Helgason CD, Damen JE, Scheid M, Duronio V, Liu L, Ware MD, Humphries RK, Krystal G (1999) The role of SHIP in growth factor-induced signaling. Prog Biophys Mol Biol 71:423–434 PubMedCAS Google Scholar
Huber M, Helgason CD, Damen JE, Scheid MP, Duronio V, Lam V, Humphries RK, Krystal G (1999a) The role of SHIP in FceRI-induced signaling. In: Daeron M, Vivier E (eds) Current topics in microbiology and immunology, immunoreceptor tyrosine-based inhibition motifs (vol 244), Springer, pp 29–41 Google Scholar
Huber M, Damen JE, Ware M, Hughes M, Helgason CD, Humphries RK, Krystal G (2000) Regulation of mast cell degranulation by SHIP. In: Marone G, Lichtenstein LM, Galli SJ (eds) Mast cells and basophils in physiology, pathology and host defense. Academic Press, San Diego, pp 169–182 Google Scholar
Hunter MG, Avalos BR (1998) Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 160:4979–4987 PubMedCAS Google Scholar
Inabe K, Ishiai M, Scharenberg AM, Freshney N, Downward J, Kurosaki T (2002) Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J Exp Med 195:189–200 PubMedCAS Google Scholar
Ishihara H, Sasaoka T, Hori H, Wada T, Hirai H, Haruta T, Langlois WJ, Kobayashi M (1999) Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 260:265–272 PubMedCAS Google Scholar
Johnson GR, Gonda TJ, Metcalf D, Hariharan IK, Cory S (1989) A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J 8:441–448 PubMedCAS Google Scholar
Jones SM, Klinghoffer R, Prestwich GD, Toker A, Kazlauskas A (1999) PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr Biol 9:512–521 PubMedCAS Google Scholar
Kalesnikoff J, Lam V, Krystal G (2002) SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival. Mol Immunol 38:1201–1206 PubMedCAS Google Scholar
Kalesnikoff J, Baur N, Leitges M, Hughes MR, Damen JE, Huber M, Krystal G (2002a) SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κ B activity. J Immunol 168: 4737–4746 PubMedCAS Google Scholar
Kashiwada M, Giallourakis CC, Pan PY, Rothman PB (2001) Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol 167: 6382–6387 PubMedCAS Google Scholar
Kavanaugh WM, Pot DA, Chin SM, Deuter-Reinhard M, Jefferson AB, Norris FA, Masiarz FR, Cousens LS, Majerus PW, Williams LT (1996) Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 6:438–445 PubMedCAS Google Scholar
Kim CH, Hangoc G, Cooper S, Helgason CD, Yew S, Humphries RK, Krystal G, Broxmeyer HE (1999) Altered responsiveness to chemokines due to targeted disruption of SHIP. J Clin Invest 104:1751–1759 PubMedCAS Google Scholar
Kimura T, Sakamoto H, Appella E, Siraganian RP (1997) The negative signaling molecule SH2 domaincontaining inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated β subunit of the high affinity IgE receptor. J Biol Chem 272:13991–13996 PubMedCAS Google Scholar
Koncz G, Toth GK, Bokonyi G, Keri G, Pecht I, Medgyesi D, Gergely J, Sarmay G (2001) Coclustering of Fcγ and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein. Eur J Biochem 268: 3898–3906 PubMedCAS Google Scholar
Krystal G (2000) Lipid phosphatases in the immune system. Semin Immunol 12:397–403 PubMedCAS Google Scholar
Lamkin TD, Walk SF, Liu L, Damen JE, Krystal G, Ravichandran KS (1997) Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J Biol Chem 272:10396–103401 PubMedCAS Google Scholar
Lecoq-Lafon C, Verdier F, Fichelson S, Chretien S, Gisselbrecht S, Lacombe C, Mayeux P (1999) Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood 93:2578–2585 PubMedCAS Google Scholar
Leitges M, Gimborn K, Elis W, Kalesnikoff J, Hughes MR, Krystal G, Huber M (2002) Protein kinase C-δ is a negative regulator of antigen-induced mast cell degranulation. Mol Cell Biol 22:3970–3980 PubMedCAS Google Scholar
Lemay S, Davidson D, Latour S, Veillette A (2000) Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol 20:2743–2754 PubMedCAS Google Scholar
Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR (1996) p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 10:1084–1095 PubMedCAS Google Scholar
Liu L, Damen JE, Cutler RL, Krystal G (1994) Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Mol Cell Biol 14 6926–6935 PubMedCAS Google Scholar
Liu L, Damen JE, Hughes MR, Babic I, Jirik FR, Krystal G (1997) The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J Biol Chem 272:8983–8988 PubMedCAS Google Scholar
Liu L, Damen JE, Ware MD, Krystal G (1997a) Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J Biol Chem 272:10998–11001 PubMedCAS Google Scholar
Liu Q, Shalaby F, Jones J, Bouchard D, Dumont DJ (1998) The SH2-containing inositol polyphosphate 5-phosphatase, ship, is expressed during hematopoiesis and spermatogenesis. Blood 91:2753–2759 PubMedCAS Google Scholar
Liu Q, Sasaki T, Kozieradzki I, Wakeham A, Itie A, Dumont DJ, Penninger JM (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 137:786–791 Google Scholar
Liu Y, Jenkins B, Shin JL, Rohrschneider LR (2001) Scaffolding protein Gab2 mediates differentiation signaling downstream of Fms receptor tyrosine kinase. Mol Cell Biol 21:3047–3056 PubMedCAS Google Scholar
Lucas DM, Rohrschneider LR (1999) A novel spliced form of SH2-containing inositol phosphatase is expressed during myeloid development. Blood 93:1922–1933 PubMedCAS Google Scholar
Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 27322:13375–13378 Google Scholar
Marchetto S, Fournier E, Beslu N, Aurran-Schleinitz T, Dubreuil P, Borg JP, Birnbaum D, Rosnet O (1999) SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor. Leukemia 13:1374–1382 PubMedCAS Google Scholar
Marshall AJ, Krahn AK, Ma K, Duronio V, Hou S (2002) TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor. Mol Cell Biol 22:5479–5491 PubMedCAS Google Scholar
Mason JM, Halupa A, Hyam D, Iscove NN, Dumont DJ, Barber DL (2002) Ship-1 regulates the proliferation and mobilization of the erythroid lineage (abstract). Blood 100:519a Google Scholar
Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP (1999) CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J Immunol 162:5719–5727 PubMedCAS Google Scholar
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765 PubMedCAS Google Scholar
Muraille E, Pesesse X, Kuntz C, Erneux C (1999) Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both nonhaemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signaling of B-cells. Biochem J 342:697–705 PubMedCAS Google Scholar
Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 95:13765–13770 PubMedCAS Google Scholar
O’Farrell AM, Parry DA, Zindy F, Roussel MF, Lees E, Moore KW, Mui AL (2000) Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation. J Immunol 164:4607–4615 PubMedCAS Google Scholar
Ono M, Bolland S, Tempst P, Ravetch JV (1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc-γ RIIB. Nature 383:263–266 PubMedCAS Google Scholar
Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV (1997) Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293–301 PubMedCAS Google Scholar
Osborne MA, Zenner G, Lubinus M, Zhang X, Songyang Z, Cantley LC, Majerus P, Burn P, Kochan JP (1996) The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J Biol Chem 271:29271–29278 PubMedCAS Google Scholar
Ott VL, Tamir I, Niki M, Pandolfi PP, Cambier JC (2002) Downstream of kinase, p62dok, is a mediator of FcγIIB inhibition of FcεRI signaling. J Immunol 168:4430–4439 PubMedCAS Google Scholar
Pesesse X, Deleu S, De Smedt F, Drayer L, Erneux C (1997) Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239:697–700 PubMedCAS Google Scholar
Pesesse X, Moreau C, Drayer AL, Woscholski R, Parker P, Erneux C (1998) The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett 437:301–303 PubMedCAS Google Scholar
Phee H, Jacob A, Coggeshall KM (2000) Enzymatic activity of the Src homology 2 domain-containing inositol phosphatase is regulated by a plasma membrane location. J Biol Chem 275:19090–19097 PubMedCAS Google Scholar
Rameh LE, Cantley LC (1999) The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 27413:8347–8350 Google Scholar
Rauh MJ, Pereira C, Palmer J, Damen J, Mui ALF, Krystal G (2002) SHIP-deficiency leads to anti-inflammatory macrophage programming and endotoxin tolerance (abstract). Blood 100:147a Google Scholar
Sattler M, Salgia R, Shrikhande G, Verma S, Choi JL, Rohrschneider LR, Griffin JD (1997) The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 15:2379–2384 PubMedCAS Google Scholar
Sattler M, Verma S, Pride YB, Salgia R, Rohrschneider LR, Griffin JD (2001) SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J Biol Chem 276:2451–2458 PubMedCAS Google Scholar
Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature 395:462–469 PubMedCAS Google Scholar
Scharenberg AM, Kinet JP (1998) PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell 94:5–8 PubMedCAS Google Scholar
Scheid MP, Huber M, Damen JE, Hughes M, Kang V, Neilsen P, Prestwich GD, Krystal G, Duronio V (2002) Phosphatidylinositol(3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation: Phosphatidylinositol(3,4)P2 is required for PKB phosphorylation at Ser473. Studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J Biol Chem 277:9027–9035 PubMedCAS Google Scholar
Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP (2001) CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 166:5480–5487 PubMedCAS Google Scholar
Siegel J, Li Y, Whyte P (1999) SHIP-mediated inhibition of K562 erythroid differentiation requires an intact catalytic domain and Shc binding site. Oncogene 18:7135–7148 PubMedCAS Google Scholar
Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29–39 PubMedCAS Google Scholar
Takeshita S, Namba N, Zhao JJ, Jiang Y, Genant HK, Silva MJ, Brodt MD, Helgason CD, Kalesnikoff J, Rauh MJ, Humphries RK, Krystal G, Teitelbaum SL, Ross FP (2002) SHIP-deficient mice are severely osteoporotic due to increased numbers of hyperresorptive osteoclasts. Nat Med 8:943–949 PubMedCAS Google Scholar
Tamir I, Stolpa JC, Helgason CD, Nakamura K, Bruhns P, Daeron M, Cambier JC (2000) The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12:347–358 PubMedCAS Google Scholar
Tridandapani S, Kelley T, Pradhan M, Cooney D, Justement LB, Coggeshall KM (1997) Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fcγ immunoreceptor tyrosine-based inhibition motif peptide motif. Mol Cell Biol 17:4305–4311 PubMedCAS Google Scholar
Tridandapani S, Pradhan M, LaDine JR, Garber S, Anderson CL, Coggeshall KM (1999) Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcγRIIb in B cells. J Immunol 162:1408–1414 PubMedCAS Google Scholar
Tridandapani S, Wang Y, Marsh CB, Anderson CL (2002) Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-κB-mediated gene transcription by phagocytic FcγRs in human myeloid cells. J Immunol 169:4370–4378 PubMedCAS Google Scholar
Tu Z, Ninos JM, Ma Z, Wang JW, Lemos MP, Desponts C, Ghansah T, Howson JM, Kerr WG (2001) Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98:2028–2038 PubMedCAS Google Scholar
Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ (2002) Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4:963–969 PubMedCAS Google Scholar
van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Lowenberg B, von Lindern M (2000) Stem cell factor induces phosphatidylinositol 3′-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells. Blood 96:3406–3413 PubMed Google Scholar
Velazquez L, Gish GD, van Der Geer P, Taylor L, Shulman J, Pawson T (2000) The shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3. Blood 96: 132–138 PubMedCAS Google Scholar
Vely F, Olivero S, Olcese L, Moretta A, Damen JE, Liu L, Krystal G, Cambier JC, Daeron M, Vivier E (1997) Differential association of phosphatases with hematopoietic coreceptors bearing immunoreceptor tyrosine-based inhibition motifs. Eur J Immunol 27:1994–2000 PubMedCAS Google Scholar
Verdier F, Chretien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P (1997) Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem 272:26173–26178 PubMedCAS Google Scholar
Ware MD, Rosten P, Damen JE, Liu L, Humphries RK, Krystal G (1996) Cloning and characterization of the human 145 kDa SHC-associated inositol 5-phosphatase, SHIP. Blood 88:2833–2840 PubMedCAS Google Scholar
Wisniewski D, Strife A, Swendeman S, Erdjument-Bromage H, Geromanos S, Kavanaugh WM, Tempst P, Clarkson B (1999) A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93:2707–2720 PubMedCAS Google Scholar
Wolf I, Lucas DM, Algate PA, Rohrschneider LR (2000) Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPd. Genomics 69:104–112 PubMedCAS Google Scholar
Xu R, Abramson J, Fridkin M, Pecht I (2001) SH2 domain-containing inositol polyphosphate 5′-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen. J Immunol 167: 6394–6402 PubMedCAS Google Scholar